Matricel develops, manufactures, and markets innovative medical devices and pharmaceutical excipients for applications in medicine and biotechnology. The main product focus are medical class III collagen implants for clinical applications in regenerative medicine.

Matricel´s proprietary technologies are the keys to successfully produce biocompatible and biodegradable matrices in a wide range of modifications suitable for the cultivation with human cells in tissue engineering and regenerative medicine. Matricel has vast experience in collagen technology and comprehensive understanding of the biological processes involved during remodelling of collagen scaffolds and the generation of the desired tissues. 

Matricel´s approved products support tissue regeneration in various medical disciplines. Matricel is active in research and development and has a promising product pipeline in different medical fields. 

Matricel also acts as a contract manufacturer for third parties.

The quality management system of Matricel is certified according to DIN EN ISO 13485 and complies with the requirements of the Medical Device Directive 93/42/EEC for the development, manufacture and marketing of biomaterials for medical, pharmaceutical and biotechnology applications.